Abbott has announced the FDA approved the Masters HP 15mm rotatable mechanical heart valve, the world's smallest mechanical heart valve,...
On 21 March 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Agilus, intended for the treatment of malignant hyperthermia in combination with adequate support measures.The applicant for this medicinal product is Norgine B.V.
RedHill Biopharma has announced that the positive final results, announced in June 2015, of the first Phase III study with...
RedHill Biopharma has announced successful final results from the first Phase III clinical study with RHB 105 for the eradication...
Objective: To develop evidence-based recommendations on the use of imaging of the joints in the clinical management of rheumatoid arthritis (RA).
Fluorescence Optical Imaging more effective than ultrasound at detecting inflammation in the absence of symptoms and signs